If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTatton Asset Management Regulatory News (TAM)

Share Price Information for Tatton Asset Management (TAM)

Share Price is delayed by 15 minutes
Get Live Data
728.00    -6.00 (-0.82%)
Bid:
728.00
Ask:
732.00
Spread: 4.00 (0.549%)
Market Cap: £441.95m
TAM Live PriceLast checked at - London Stock Exchange

Intraday Tatton Asset Management Share Chart

Issue of Equity and PDMR Dealing

1 Nov 2021 07:00

RNS Number : 8209Q
Tatton Asset Management PLC
01 November 2021
 

 

Tatton Asset Management plc

(or "the Company") 

 

Exercise of Options and PDMR Dealing

 

Tatton Asset Management PLC (AIM: TAM), the on-platform discretionary fund management (DFM) and IFA support services business announces that it has issued an aggregate 9,473 ordinary shares of £0.20 each ("Ordinary Shares") to Paul Edwards, Chief Financial Officer and PDMR, who has elected to exercise his options pursuant to the Company's Save As You Earn ("SAYE") employee share scheme.

Following the exercise, Paul will be interested in 495,224 Ordinary Shares, representing approximately 0.84 per cent. of the Company's issued Ordinary Share capital.

Admission and Total Voting Rights

Application has been made for the newly issued shares to be admitted to trading on AIM, and admission is expected to take place on 2 November 2021 ("Admission"). Following Admission, the Company's issued share capital will consist of 58,914,887 ordinary shares. There are no ordinary shares held in treasury. Therefore, following Admission, this figure of 58,914,887 should be used by shareholders as the denominator for the calculation by which they determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

For further information please contact:

Tatton Asset Management plc

Paul Hogarth (Chief Executive Officer)

Paul Edwards (Chief Financial Officer)

Lothar Mentel (Chief Investment Officer)

+44 (0) 161 486 3441

 

Zeus Capital - Nomad and Broker

Martin Green (Corporate Finance)

Dan Bate (Corporate Finance and QE)

 

+44 (0) 20 3829 5000

 

Singer Capital Markets - Joint Broker

Peter Steel, Rachel Hayes, Amanda Gray (Investment Banking)

+44 (0) 20 7496 3000

 

 

Belvedere Communications - Financial PR

John West / Llew Angus (media)

Cat Valentine / Keeley Clarke (investors)

+44 (0) 7407 023147

+44 (0) 7715 769078

tattonpr@belvederepr.com

 

Trade Media Enquiries

Roddi Vaughan Thomas (Head of Communications)

+44 (0) 7469 854 011

 

For more information, please visit: www.tattonassetmanagement.com

 

 

The information below, set out in accordance with the requirements of the MAR, provides further detail.

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Paul Edwards

2

Reason for the notification

a)

Position/status

PDMR, Chief Financial Officer

b)

 

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Tatton Asset Management plc

b)

LEI

213800G2F8I1N7HTVP88

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares of £0.20 each

ISIN: GB00BYX1P358

b)

Nature of the transaction

 

Exercise of Options (SAYE Scheme)

 

c)

Price(s) and volume(s)

Price: £1.90

Volume: 9,473

 

 

 

d)

Aggregated information

- Aggregated volume

- Price

 Price : £1.90

Volume: 9,473

e)

Date of the transaction

1 November 2021

f)

Place of the transaction

London stock Exchange, AIM

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHDKDBDBBDBQKN
Date   Source Headline
19th Jun 20267:00 amRNSNotice of AGM
18th Jun 20268:16 amRNSHolding(s) in Company
17th Jun 202610:04 amRNSPDMR Dealing
16th Jun 20267:00 amRNSAudited Final Results
26th May 20267:00 amRNS-RNotice of Investor & Analyst Presentations
22nd May 20262:51 pmRNSHolding(s) in Company
21st May 202610:07 amRNSHolding(s) in Company
8th May 20264:47 pmRNSHolding(s) in Company
8th May 20262:19 pmRNSPDMR Dealing
7th May 202611:16 amRNSPDMR Dealing
27th Apr 20269:24 amRNSHolding(s) in Company
15th Apr 20267:00 amRNSTrading Update and Notice of Final Results
18th Mar 20267:00 amRNSPDMR Dealing
6th Mar 20267:00 amRNSPDMR Dealing
5th Mar 20267:00 amRNSExercise of Options and TVR
13th Feb 20268:58 amRNSPDMR Dealing
2nd Feb 20264:52 pmRNSBlock Listing Update
30th Jan 20269:11 amRNSPDMR Dealing
12th Dec 202512:47 pmRNSPDMR Dealing
10th Dec 20257:00 amRNSPurchase of Shares by EBT
28th Nov 20253:22 pmRNSShare purchase by a Non-Executive Director
18th Nov 20257:00 amRNSUnaudited Interim Results
28th Oct 20257:00 amRNS-RNotice of Investor & Analyst Presentations
17th Oct 202512:41 pmRNSPDMR Dealing
15th Oct 202510:56 amRNSExercise of Options, PDMR Dealing and TVR
14th Oct 20257:00 amRNSTrading Update and Notice of Results
5th Sep 20252:25 pmRNSPDMR Dealing
4th Sep 20253:14 pmRNSHolding(s) in Company
29th Aug 202510:30 amRNSOptions Exercise, PDMR Dealing, Block Listing, TVR
13th Aug 20254:03 pmRNSExercise of Options and TVR
12th Aug 20257:01 amRNSAppointment of Joint Broker
12th Aug 20257:00 amRNSRelated Party Transaction
24th Jul 20254:15 pmRNSResult of AGM
22nd Jul 202512:17 pmRNSExercise of Options, PDMR Dealing and TVR
14th Jul 20255:20 pmRNSHolding(s) in Company
10th Jul 20254:52 pmRNSHolding(s) in Company
9th Jul 202510:59 amRNSHolding(s) in Company
26th Jun 20251:56 pmRNSExercise of Options, PDMR Dealings and TVR
23rd Jun 20252:12 pmRNSNotice of AGM
16th Jun 202511:42 amRNSHolding(s) in Company
10th Jun 20257:00 amRNSFinal Results
13th May 20257:00 amRNS-RNotice of Investor & Analyst Presentations
15th Apr 20257:00 amRNSTrading Update and Notice of Chairman’s Retirement
28th Mar 20253:29 pmRNSDirector Appointment
14th Feb 20254:31 pmRNSPDMR Dealings
5th Feb 20254:37 pmRNSGrant of Options and PDMR Dealing
21st Jan 202510:31 amRNSExercise of Options and PDMR dealings
13th Nov 20247:00 amRNSUnaudited Interim Results
17th Oct 202411:52 amRNSHolding(s) in Company
15th Oct 20247:00 amRNSTrading Update and Notice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.